A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study

Wranke, A.Yurdaydin, C.Heidrich, B.Kalliopi, Z.Yalcin, K.Fehmi, T.Akarca, U.2024-04-242024-04-2420180168-82781600-0641https://doi.org/10.1016/S0168-8278(18)31261-3https://hdl.handle.net/11468/16297International Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCE[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 studyA virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 studyConference Object68S507S507WOS:00046106860222810.1016/S0168-8278(18)31261-3Q1